Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of
Gold Royalty shares are trading lower by 19.3% during Tuesday's session. The company announced that it entered into a binding agreement to acquire a copper stream on the Vares Silver Project.